Publication Date
| In 2026 | 0 |
| Since 2025 | 0 |
| Since 2022 (last 5 years) | 1 |
| Since 2017 (last 10 years) | 1 |
| Since 2007 (last 20 years) | 1 |
Descriptor
| Adults | 1 |
| Behavior Problems | 1 |
| Drug Therapy | 1 |
| Drug Use | 1 |
| Foreign Countries | 1 |
| Guidelines | 1 |
| Intellectual Disability | 1 |
| Quality of Life | 1 |
Source
| International Journal of… | 1 |
Author
| Audenaert, K. | 1 |
| Claes, C. | 1 |
| Gérard, S. | 1 |
| Laermans, P. | 1 |
| Lombardi, M. | 1 |
| Morisse, F. | 1 |
| Vandevelde, S. | 1 |
| de Kuijper, G. | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
| Australia | 1 |
| Canada | 1 |
| France | 1 |
| Germany | 1 |
| Netherlands | 1 |
| New Zealand | 1 |
| United Kingdom | 1 |
| United States | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkLaermans, P.; Morisse, F.; Lombardi, M.; Gérard, S.; Vandevelde, S.; de Kuijper, G.; Audenaert, K.; Claes, C. – International Journal of Developmental Disabilities, 2023
Introduction: Adults with intellectual disabilities have an increased vulnerability to mental health problems and challenging behaviour. In addition to psychotherapeutic or psychoeducational methods, off-label pharmacotherapy, is a commonly used treatment modality. Objective: The aim of this study was to establish evidence-based guideline…
Descriptors: Adults, Intellectual Disability, Drug Therapy, Behavior Problems
